Meet the Venture Leaders Biotech 2025: ten Swiss Biotech startups announced for the Boston roadshow
The ten selected startups representing the Swiss National Startup Team will take part in a unique opportunity to expand their networks and business knowledge in Boston this June. Join us for the presentation of the participating startups at the Swiss Biotech Days in Basel from 17:45 until 18:30 in room “Singapore” on May 5th, 2025.
“Getting ready for this roadshow for the 20th year is a great reflection of the quality of innovation of the new startups involved,” said Jordi Montserrat, Managing Partner of Venturelab. “I’m looking forward to being part of this new edition and assisting the team as they expand internationally.”
Meet the Swiss National Startup Team:
- Abrinca Genomics: Transforming microbial genomics research.
- Amporin Pharmaceuticals: Acute membrane repair for deadly degenerative diseases.
- Apricot Therapeutics AG: Data-driven drug discovery for targeted medicine.
- Aukera Therapeutics: Our drugs keep the cell’s growth engine mTORC1 in check.
- ENANTIOS: Solution to analyze chiral molecules and biologics.
- Encelta: Providing healthy immune cells to patients in need.
- HemostOD: Ex Vivo platelet manufacturing.
- InkVivo Technologies AG: Best in class polymer platform for formulating drug delivery.
- Juvion Health Sciences: Narrowing the gap between lifespan and healthspan.
- nerai bio: Next-gen CRISPR editors for safe, efficient gene therapies.
The Swiss National Startup Team’s roadshow to Boston is organized by Venturelab in partnership Swissnex in Boston and New York, supported by University of Basel, EPFL, ETH Zürich, Hansjörg Wyss, Kellerhals Carrard and VISCHER.
